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Abstract: COVID-19 has proven to be a formidable challenge for many countries in the European Union
to manage effectively. The European Union has implemented numerous strategies to face emerging
issues. Member States have adopted measures such as the closure of borders and significant limitations
on the mobility of people to mitigate the spread of the virus. An unprecedented crisis coordination
effort between Member States has facilitated the ability to purchase equipment, personal protective
equipment, and other medical supplies. Attention has also been focused on providing substantive
money for research to find a vaccine and promote effective treatment therapies. Financial support has
been made available to protect worker salaries and businesses to help facilitate a return to a functional
economy. Lessons learned to date from COVID-19 in the European Union are many; the current
crisis highlights the need to think about future pandemics from a population-based management
approach and apply outside the box critical thinking. Due to the complexity, intensity, and frequency
of complex disasters, global leaders in healthcare, government, and business will need to pivot from
siloed approaches to decision-making to embrace multidisciplinary and transdisciplinary levels of
cooperation. This cooperation requires courage and leadership to recognize that changes are necessary
to avoid making the same mistakes we have planned countless times on avoiding. This study focuses
on the European Union’s initial response to the COVID-19 pandemic, starting with how the European
Union first learned and processed the global information arising out of China, followed by the
incremental population-based medicine/management decisions made that currently are defining
the European Union’s capacity and capability. The capacity to organize, deliver, and monitor care
to a specific clinical population under a population-based management target includes strict social
distancing strategies, contact testing and tracing, testing for the virus antigen and its antibodies,
isolation, and treatment modalities such as new mitigating medications, and finally, a vaccine.
Keywords: coronavirus; COVID-19; European Union preparedness; pandemics; disaster; crisis;
crisis management
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1. Introduction
The primary treatments of patients presenting for healthcare worldwide are managed by individual
practitioners trained in “one-on-one care focused on individual patient interactions and encounters with
ill individuals” [1]. Increasingly, especially in hospital settings, a wide variety of health professions now
practice team-based care, but the focus remains on individual patient interactions [1]. Population-based
medicine/management (PBM) places the individual within the context of a broader community,
composed of both ill and well individuals when the entire population is at risk.
PBM must focus on social and structural factors that impact the health of communities, cities,
and entire countries to improve the health outcomes of both individuals and the population
while improving efficiency and reducing costs [2]. Due to the rising frequency of complex crises
worldwide, healthcare providers have been forced to better recognize and participate in the complex
management of PBM events that impact both individuals and the populations in which they live.
Moreover, health reform is all about practicing PBM, and the only way we can bend the cost curve is by
keeping people out of the hospital; thereby, reducing unnecessary utilization. In this use, population
health improvement emphasizes the central role of the primary care provider, a fully engaged patient,
and care coordination [3].
A crisis is any event that is going to lead to an unstable and dangerous situation affecting an
individual, group, community, or the whole society. Crises are deemed to be negative changes in
security, economic, political, societal, or environmental affairs, mainly when they occur abruptly,
with little or no warning. More loosely, it is a term meaning "a testing time" or an "emergency event" [4].
Modern-day health care providers have traditionally only focused on meeting the response phase
requirements of disasters. The emergence of complex global public health crises such as increasing
zoonotic infectious diseases, climate change and its extremes, biodiversity loss, emergencies of
scarcity, rapid, unsustainable urbanization, migrant and refugee surges, domestic and international
terrorism, cyber-security, the civilianization of war and conflict, and the global rise of resistant
antibiotics have increased direct and indirect mortality and morbidity [5]. These crises are beyond
the current decision-making and operational capabilities of traditional disaster management and
its providers, most of whom are community-level practitioners representing every discipline.
Successful management requires unprecedented multidisciplinary and transdisciplinary levels of
cooperation among decision-makers that include economic and political powers. Focusing on the
disproportionate burden that a pandemic causes, multidisciplinary teams are involved in everything
from disease prevention and control to public health, the economy, politics, and the geopolitical impact
among nations [6]. Some countries have done well in managing the current Coronavirus Disease 2019
(COVID-19) pandemic, while others have failed.
This study focuses on the European Union’s (EU) initial response to the COVID-19 pandemic,
starting with how the EU first learned and processed the global information arising out of China,
followed by the incremental PBM decisions made that currently define the EU’s capacity and capability
today [7]. The authors believe that historical documentation of PBM including strict social distancing
strategies (SDS), contact testing and tracing, testing for the virus antigen and its antibodies, isolation,
and treatment modalities such as new mitigating medications, and finally, a vaccine, is crucial to the
EU’s understanding of the multidisciplinary requirements posed by a pandemic and serves as an
essential learning tool for future improvements.
2. Global Emergence of COVID-19
COVID-19 is a disease caused by a new type of coronavirus (SARS-CoV-2), first identified in the
Chinese municipality of Wuhan in late December 2019. The virus quickly spread to other regions
of China and the world. By 20 January 2020, there were reports of confirmed exported cases from
Thailand, Japan, and South Korea [8]. During the outbreak, the Chinese changed the case definition
several times, which caused uncertainty regarding the exact number of cases and the extent of the
spread of the virus. Consequently, several European Union/European Economic Area (EEA) countries
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had to modify their testing strategies during the outbreak to test only symptomatic or severe cases [9].
By the end of January 2020, isolated cases appeared in some EU Member States [10]. The first European
case, with a travel history to China, was reported from France on 24 January 2020 [11]. In Germany,
cases were reported on 28 January, related to a person visiting from China [12]. The first Swedish case
was confirmed on 31 January 2020, related to a woman who had visited Wuhan a couple of weeks
earlier [10]. On 30 January 2020, the World Health Organization (WHO), declared the first outbreak of
a novel coronavirus, a public health emergency of international concern [8]. At the end of February
2020, Italy reported a significant increase of COVID-19 cases concentrated in the northern regions of the
country. By March 2020, all EU Member States had reported COVID-19 cases (Figure 1). The number
of cases has since continued to increase to 200,000 [13]. The European Council, together with other
EU institutions, continues close monitoring and actions taken to date [9]. Those actions include the
adoption of relevant EU legislation and ongoing coordination with Member States to share information,
assess needs, and ensure a coherent EU-wide response. The WHO is coordinating the worldwide
response and declared COVID-19 a global pandemic on 11 March 2020 [8]. The EU is directly
contributing to the global response of the WHO by producing daily reports, guidelines, information,
and registration of relevant data regarding the number of affected and deaths [14].
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Figure 1. Global Emergence of COVID-19.
3. The EU’s Response
The EU’s response to COVID-19 has focused, to date, on several priorities to take control of the
pandemic (Figure 2). EU leaders agreed on the following priorities during video conference meetings
on 17 March and 26 March 2020: public health, travel and transportation, research and innova on ,
economy, risis management and solidarity, and education. Article 3 f the Council Implementi g
Decision defines a crisis as a "situati n of such a wi e-r nging impact or political significance, that it
requires timely policy coordination and response at the Union political level" [15]. The conclusions
achiev d at the meeting we e based on prior discussions, which commenced on 10 Marc 2020, with the
Europ an Central Bank (ECB) Presi e t, the Pre ident of the Euro-group, an the High Representat ve.
M mbers of the European Council agr ed to collaborate in previously enumerated major areas to
fight the pandemic [15]. The m eting confirmed the need to implement r stricted border movements
th t are nforced to decrease the spread of the virus. Personal Pro ectiv Equip ent (PPE) requir
t support the fight with th pandemic is to be purchased through t civil protection fram work
financed by EU funds, coordinated by the European Commission [16]. A coordinated and transparent
process needs to be undertaken to share and support any d velopments in research concer ing the
novel public health threat, amongst all the supporting Advisory Groups on COVID-19 [9].
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4. Challenges to Limiting the Spread: Borders and Mobility
The EU strives to join efforts with its Member States to contain the spread of the virus.
Significant border restrictions were implemented to serve that purpose, as EU leaders decided
on imposing temporary restrictions on non-essential travel to the EU for 30 days [17]. The European
Commission, based on the scarce data concerning virus spread and development, had suggested
a month-long restriction to help contain the outbreak and boost Europe’s healthcare system to cope
with an antic pated surge of patients. Seve al EU countries closed their borders in March. For example,
Poland closed its borders to foreigners on 15 March 2020. Although Polish citizens could return to
Poland, they are subjected to a mandatory 14-day home quarantine. International flights and rail
connections have been susp d , except for cargo trans rt works [18]. Essential transport f goods
is still permitted across Polish borders. Sweden closed its border on 19 March 2020 for an initial period
of 30 days [15].
The EU Council activated the EU integrated political crisis response mechanism (IPCR) on
28 January 2020 [19]. This is a "tool" in the hands of the Presidency to coordinate the political response
to major cross-sectoral and complex crises, including acts of terrorism that require multidisciplinary
an transdisciplinary thinking, cooperation, nd management. IPCR aims to improve EU flexibility
when crisis response mechanisms are concerned. The critical responsibility belongs to the Permanent
Representatives Committee (COREPER), which acts as a representative of the Member States, and the
Council and its different bodies and agencies. This enables more flexible communication and timely
decision-making processes [20]. Changes to information sharing as IPCR is implemented allow Member
States to receive unrestricted access to regular reports by the European Commission and European
External Action Service concerning the current situation and its analysis. Furt ermore, there is
a dedicated page on a secured web pl tform where current i formation is shared [21]. The European
Commission and the Council are facilitating permanent contact and coordination among national
health and interior ministries [22]. All national authorities are required to provide immediate spending
towards fighting the pandemic as a key fiscal target.
The European Centre for Disease Control (ECDC) is issuing a continuous risk assessment for the
EU population. Rapid risk/outbreaks assessment aim at supporting the countries and the European
Commission in th ir prepar dness and response to a public health threat. They provide a timely
summary and risk assessment of a public health threat for EU/EEA countries related to a specific
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event. They also include potential options for response. As outbreaks or public health events
develop, ECDC may issue updated risk assessments. The essential functions of ECDC are surveillance,
epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training,
international relations, and health communication. ECDC has developed a dedicated webpage for the
pandemic outbreak (COVID-19) updates and risk assessments with a focus on Europe [23]. Their journal
Eurosurveillance fast tracks reports concerning up-to-date scientific data on the virus spread and its
consequences [9].
The EU is also committed to countering disinformation on the virus with transparent, timely,
and fact-based communication. The European External Action Service (EEAS) publishes reports such
as the Short Assessment of Narratives and Disinformation Around the COVID-19 Pandemic, which has
been released to the public alert for disinformation [23].
5. Ensuring the Provision of Medical Equipment
Regarding the assessment of safety and performance of medical devices and personal protective
equipment, national authorities should share best practices and seek a consensus on common approaches
with the assistance of notified bodies as appropriate. Member States should set up a single contact
point for all questions related to personal protective equipment and medical devices to link testing
bodies and relevant market surveillance authorities [22]. Companies can focus on manufacturing
critical medical devices to avoid shortages or delays when lives are at stake. Additionally, lowering the
barriers to access medical equipment and supplies is facilitated by lifting customs, duties, and VAT for
the import of medical devices and PPE from lower-income countries [8]. The EU is working together
with its Member States to ensure the provision of personal protective equipment and medical supplies
and to support healthcare systems across Europe through the following means:
• Joint public procurement for facemasks and other PPE. On 19 March, rescEU stockpiling
was created, a common European reserve of medical equipment such as ventilators, PPE,
reusable masks, vaccines and therapeutics, and laboratory supplies, financed at 90% by the EU
Commission [24].
• Close contacts with the European industry to increase the production of all necessary supplies.
The Commission announced four official calls to gather medical equipment and supplies for
health systems in member countries (28 February, 17 and 19 March 2020), with 25 Member States
responding to the request. The first call resulted in offers matching the requested amounts.
The contracts concerning those calls were underway in the coming weeks, with distribution to
member states of equipment and supplies expected shortly afterward. The European Commission
coordinated revised harmonized standards enabling manufacturers to introduce into the market
more PPE devices for patients, health care workers, and citizens in general [24].
• Regulated exports of personal protective equipment from the EU to ensure supply in all Member
States. Member States are responsible for the issuance of authorizations. However, the process
is managed by the Emergency Response Coordination Centre (ERCC), and for any questions
concerning the supply of PPE within the EU, the Member States may refer to the ERCC. The Centre
runs 24/7 and aims to help any country inside or outside the EU affected by a major disaster
upon request from the national authorities or a United Nations (UN) body. The agency also is
responsible for emergency communication and monitoring of instruments through the Common
Emergency Communication and Information System (CECIS), a web-based alert and notification
application enabling real-time exchange of information.
• Priority lanes to facilitate the free circulation of goods and people who need to cross borders.
The implementation of the Union’s policies is governed by the principle of solidarity among
the Member States. To avoid shortages and avoid worsening the existing social and economic
difficulties, Member States should not undertake measures that jeopardize the integrity of the
Single Market for goods, of supply chains, or engage in any unfair practices. They must always
admit their citizens and residents, and facilitate the transit of other EU citizens and residents who
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are returning home. New guidelines set out principles for an integrated approach to effective
border management to protect health while preserving the integrity of the Single Market [25].
Additionally, under the union civil protection mechanism, the EU has new possibilities to
strengthen cooperation between the EU Member States and six Participating States in the field of civil
protection, to improve prevention, preparedness, and response to disasters. When the scale of an
emergency overwhelms the response capabilities of a country, it can request assistance via the ERCC.
The European Commission plays a key role in coordinating the response to disasters in Europe and
beyond, and contributes to at least 75% of the transport and/or operational costs of deployment [24,26].
The EU has effectively broadened its involvement by undertaking the following initiatives:
facilitated the sourcing for additional personal protective equipment, especially medical masks;
activated the Emergency Response Coordination Centre, to coordinate support 24/7; and created a new
common European reserve of emergency medical equipment, such as ventilators, protective masks,
and laboratory supplies to help EU countries in need.
6. Promoting Research for Treatments and Vaccines
Another crucial initiative includes promoting research for treatments and vaccines.
On 1 April 2020, EU Commission scientists presented innovative test control procedures for reliable
verification of up to 60 million laboratory tests throughout the EU [24]. Sampling methods can
accurately evaluate the functioning of coronavirus tests reducing false negatives and requiring a minute
quantity of sample material to be used [8]. The EU is fast-tracking and promoting research on COVID-19
by mobilizing €47.5 million for 17 projects for vaccines and treatment via the EU’s Horizon 2020,
which is the most extensive EU Research and Innovation program ever, with nearly €80 billion of
funding available over seven years (2014 to 2020). In addition to the private investment that this money
will attract, it also promises more breakthroughs, discoveries, and world-firsts by taking great ideas
from the lab to the market. Other research funding sources include €90 million in public and private
funds for therapeutics and diagnostics via the Innovative Medicines Initiative (IMI). The European
Innovation Council accelerator program provides €164 million for small- and medium-sized enterprises
(SMEs), and startups for innovative solutions to tackle the COVID-19 outbreak [19].
7. Supporting Employment, Businesses, and the Economy
Due to severe disruption in private sectors, especially in sectors affected by the virus spread,
and those undertaking actions towards limiting its spread, member countries are required to
provide security measures to protect those affected by bankruptcy, e.g., companies and workers [19].
Safety economic packages are being implemented across Europe, e.g., UK, and Germany (13 March
2020); Italy (17 March 2020); Sweden (16 March 2020); France (18 March 2020); Poland (18 March 2020);
Belgium (22 March 2020; and the Czech Republic (23 March 2020) [27]. In Poland, the government
proposed deferral of tax payments, a possible exemption from tax terms, assistance with the payment
of employee wages in distressed firms, and other preferential loans with preferred terms, along with fee
waivers [18]. In Sweden, several measures were undertaken to provide economic support to affected
sectors of the economy. This included temporary exemption from tax payment and social expenses,
easier procedures for sick leave, etc. [28].
The next fundamental task comprises supporting jobs, businesses, and the general economy.
It aims to provide rapid support to workers and alleviate the unemployment risks brought upon by the
outbreak. The main instrument in that fight is Support mitigating Unemployment Risks in Emergency
initiatives (SURE).
The SURE instrument will be available to the Member States that need to mobilize significant
financial means to fight the negative economic and social consequences of the coronavirus outbreak in
their territory. It will provide financial assistance to Member States to address sudden increases in
public expenditure for the preservation of employment. Specifically, the SURE instrument will act
as a second line of defense, supporting short-time work schemes and similar measures, to help the
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Member States protect jobs and thus, employees and self-employed against the risk of unemployment
and loss of income [29]. The establishment of SURE is a further tangible expression of Union solidarity,
whereby the Member States agree to support each other through the Union by making additional
financial resources available through loans [29].
EU delegations are working with Member States’ embassies to coordinate the repatriation of EU
citizens. Help was provided to European nationals in Algeria by organizing a flight by the Polish
Embassy on 17 March 2020 to Warsaw [27]. The support received about 630 EU citizens arriving
from Iran [30]. When most airlines had stopped their services, the coordination at both the national
and local level resulted in the safe return of about 630 EU citizens. Thanks to the coordinated local
efforts, sufficient capacity could be organized at commercial airlines, so it was not necessary to activate
the EU Civil Protection Mechanism. The Directorate-General for European Civil Protection and
Humanitarian Aid Operations (DG ECHO) monitored the situation closely [31]. DG ECHO is the
Directorate-General for European Civil Protection and Humanitarian Aid Operations with the primary
mission of preserving lives, preventing, and alleviating human suffering, and safeguarding the integrity
and dignity of populations affected by natural disasters and human-made crises. Headquartered in
Brussels, it has a global network of field offices, which can ensure the rapid and effective delivery of
EU relief assistance [32].
Examples of relief assistance include supporting 30,000 EU tourists who were stranded in Morocco
to be able to return home, as well as support in repatriating around 10,000 British, Norwegian,
and Swedish citizens [1]. Similar assistance was delivered to EU citizens in Africa, Asia, and the
Pacific, as well as Latin America and the Caribbean. The EU and its Member States are taking action to
minimize the fallout to the economy due to the COVID-19 outbreak. EU funds totaling €37 billion
will be allocated to the Coronavirus Response Investment Initiative to support healthcare systems,
small- and medium-sized enterprises (SMEs), and labor markets. Poland, Spain, Italy, Romania,
and Hungary are the largest beneficiaries of EU support.
Member countries will not have to contribute to the planned new fund. The program covers
expenses incurred by EU countries from 1 February 2020. Up to €28 billion of structural funds from
2014-2020, national budgets not yet allocated to the project, are to become eligible for crisis response.
These funds include up to €800 million from the EU Solidarity Fund to be directed to the countries
hardest hit [22].
The European Investment Bank has made available up to €40 billion to bridge the short-term
financing needs of SMEs. This fund has promoted flexibility in the application of EU rules to state
aid measures to support businesses and workers, public finance, and fiscal policies to accommodate
exceptional spending. Altogether, the EU and its Member States are mobilizing 2% EU GDP in
fiscal measures with 13% EU GDP in liquidity support. In addition, the European Central Bank also
announced €750 billion pandemic emergency funding [22].
8. Crisis Coordination
Considering the changing situation and the different sectors affected (health, consular,
civil protection, economy), the Croatian Presidency decided to activate the EU’s IPCR in information
sharing mode, on 28 January 2020. IPCR is the EU framework for the coordination of cross-sectoral
crises at the highest political level. The idea is based on the notion that crises are inevitable and can hit
several countries within the EU. To manage such a crisis, involving many countries, there is a need
for collaboration, coordination, communication, and information sharing. IPCR offers the possibility
of (a) sharing existing crisis reports, (b) 24/7 contact points, (c) analytical reports, (d)a web platform
to exchange and collect information, (e) crisis meetings with EU ambassadors or ministers, and (f)
proposals for EU actions decided by the European Council or the Council to the EU. These actions can
be conducted stepwise in three distinct operational modes: monitoring (a and b), information sharing
(a, b, c, and d), and a combination of all the above. The information-sharing mode means that Member
States have access to regular situational awareness and analysis reports by the European Commission
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and the European External Action Service. The Integrated Situational Awareness and Analysis (ISAA)
Intel is based on relevant information and analysis provided by the Member States (e.g., from relevant
national crisis centers), mainly through the web platform [22].
On 2 March 2020, the Presidency escalated the activation of the IPCR mechanism to full mode
(meaning from information-sharing mode to preparing, developing, and updating proposals for
actions at crisis presidency-led roundtables for the Council). The full activation mode allows for crisis
roundtables with the participation of affected Member States: The European Commission, The European
External Action Service, The office of the President of the European Council, and Relevant EU agencies
and experts.
9. Limitations
Significant limitations occur when PBM is understood and practiced by healthcare providers but
not by political and economic decision-makers when they legislate to make exceptions to mitigate SDS.
The EU has performed well in this regard compared to the United States, for example. This includes
understanding that the only two population-based management options the healthcare community has
are SDS and vaccines. SDS, unfortunately, has been started too late and ended too soon, with some EU
countries taking liberties or providing exceptions with SDS decisions allowing openings for the virus
to thrive. It is an ’all or nothing’ concept and practice that is integral to the understanding and success
of PBM. Included in PBM are timely provisions for contact tracing, which is also imperfect if not done
completely, virus antigen and antibody testing, isolation, and treatment with new medications to
mitigate the illness and lastly, a vaccine itself. Without SDS, the number of patients now dependent
upon the later provisions of PBM care, except for a future vaccine, have become insurmountable
for some.
10. Conclusions
COVID-19 has proven that a disaster does not need to be a terrorist attack or a war with a known
opponent. The enemy can simply be invisible with devastating consequences. One positive impact of
the current pandemic is the time it offers to different nations to reflect on past events and learn what can
be improved for future responses. Managing future crises demands trained leadership and functional
infrastructure. A sound and strong leadership capable of making proper and quick decisions based on
limited information is a crucial part of disaster and major incident management, and is needed at all
levels of management from local to national and international [33]. Decisions should be made in favor
of public health, not on political or economic imperatives. Unfortunately, many decisions made during
the current crisis were focused more on political and economic considerations rather than public safety
and security. Consequently, the outcome has suffered because of late engagement in crisis management,
and failure to implement timely and crucial social distancing strategies, resulting in the loss of life and
credibility [34]. While SDS measures vary, are inconsistent, and late in many circumstances, it has been
proven to be the most critical element in preventing the spread and mitigating deaths [35].
In revisiting the requirement for capacity surge, there has been a wide range of shortcomings in
the current situation that merits in-depth analysis and the development of new conceptual frameworks
to understand and manage surge capacity for pandemics [36].
A highlight of the current crisis is the engagement and willingness of the medical staff to work
and show up at work. Many healthcare professionals risk their lives and leave their families for the
work they have been trained for. Although the same attitudes have been demonstrated in many
communities, the community roles in providing consistent support to medical staff for childcare, as an
example, are essential [37].
Additionally, new initiatives that were made by many companies to shift their production to
what was needed proved essential. There is no space for error in just-in-time delivery, and any minor
shortcomings can result in major emergencies [38].
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Guidelines and instructions are necessary for the smooth management of chaotic situations.
Triage has been used in many years to bring order to chaos, however, the ethical and moral dilemma
associated with a pandemic such as COVID-19 requires additional study [39]. The current crisis has
shown that when resources are scarce, difficult decisions must be made. These measures should be
practiced continuously to create both staff and public awareness of all problematic decisions that must
be made by leaders and easily comprehended by the public. A reliable fail-safe information system
is necessary [40,41]. It should be independent of all sociopolitical relations to avoid misinformation
and confusion that can be associated with short-term wins. Investing in civilian first- aid education,
basic hygienic knowledge, etc., can be of importance for future crisis management policies.
Although new technologies can create additional difficulties, within the COVID-19 crisis,
opportunities have emerged to apply innovative solutions. Implementing telehealth consultations,
the use of media for information sharing, and webinars for sharing knowledge and expertise have
seen widespread adoption during the COVID19 pandemic.
It is crucial that citizens rely only on authoritative sources to get updated information on the
COVID-19 outbreak [42].
Future policy and decision-making in the EU, and globally, should incorporate thorough
after-action reports and government commissions to investigate best practices and lessons learned
from the COVID-19 pandemic. There is a need for strong containment, strong coordination,
resource availability, political responsibility, and educational initiatives. There is especially a lack of
proper training in which all issues such as ethical and moral concerns can be discussed. There is also
a need to learn the principles of protection and prevention of infectious diseases. Closer collaboration
is called for with the military which will allow for more effective resource distribution and shared
information about future global threats. Disaster medicine and public health components of the
curriculum should be incorporated into medical education [43]. Medical management and measures
should cover all phases of disaster management, based on the new proactivity paradigm announced
by the WHO [44,45]. Health organizations should be able to work independently, avoiding political
partnership and decision-making. Political interference must cease. Population-based management
and public education are imperative pillars from which future pandemic and disaster planning and
response emanate from.
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